| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pathology and Laboratory Medicine [J. C. B., R. A. F.], Curriculum in Genetics and Molecular Biology [R. A. F.], and the Lineberger Comprehensive Cancer Research Center [R. A. F.], University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599
Dinucleotide repeats, because of their repetitive nature, are prone to frameshift mutations, most likely via a DNA-polymerase slippage mechanism. Mutation rates in microsatellite DNA sequences are high in mismatch repair-defective cells. In normal cells, only estimates of maximal rates of mutation in microsatellites have been possible previously, because of the low sensitivity of screening assays for mutations in endogenous sequences. We have measured the spontaneous mutation rate of a dinucleotide repeat in diploid human foreskin fibroblasts. In our system, the mutation target is a (CA)17 repeat contained within a stably integrated plasmid. The repeat disrupts the reading frame of a neomycin (neo) resistance gene within the plasmid. Cells containing frameshift mutations in the CA repeat that correct the reading frame of the neo gene are selected using the neo analogue G418. This system of measuring microsatellite mutation rates is highly sensitive, because there is a specific target within which mutations can be selected. Fluctuation analysis of cells containing the target DNA yielded mutation rates of <3.1 x 10-8 to 44.8 x 10-8 mutations/cell/generation. This is the first report of a direct measurement of a spontaneous mutation rate of a microsatellite sequence in normal human cells.
1 Supported by NIH Grant CA63264.
2 To whom requests for reprints should be addressed, at Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine, Campus Box 7525, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599. Phone: (919) 966-6920; Fax: (919) 966-0717; E-mail: rfarber@med.unc.edu.
Received 2/10/98. Accepted 7/ 3/98.
This article has been cited by other articles:
![]() |
P. Cejka, G. Marra, C. Hemmerle, E. Cannavo, Z. Storchova, and J. Jiricny Differential Killing of Mismatch Repair-Deficient and -Proficient Cells: Towards the Therapy of Tumors with Microsatellite Instability Cancer Res., December 1, 2003; 63(23): 8113 - 8117. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Boyer, N. A. Yamada, C. N. Roques, S. B. Hatch, K. Riess, and R. A. Farber Sequence dependent instability of mononucleotide microsatellites in cultured mismatch repair proficient and deficient mammalian cells Hum. Mol. Genet., March 1, 2002; 11(6): 707 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Laiho, V. Launonen, P. Lahermo, M. Esteller, M. Guo, J. G. Herman, J.-P. Mecklin, H. Jarvinen, P. Sistonen, K.-M. Kim, et al. Low-Level Microsatellite Instability in Most Colorectal Carcinomas Cancer Res., February 1, 2002; 62(4): 1166 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. N. Roques, J. C. Boyer, and R. A. Farber Microsatellite Mutation Rates Are Equivalent in Normal and Telomerase-immortalized Human Fibroblasts Cancer Res., December 1, 2001; 61(23): 8405 - 8407. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Ji and M.-C. King A functional assay for mutations in tumor suppressor genes caused by mismatch repair deficiency Hum. Mol. Genet., November 1, 2001; 10(24): 2737 - 2743. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zienolddiny, D. Ryberg, and A. Haugen Induction of microsatellite mutations by oxidative agents in human lung cancer cell lines Carcinogenesis, August 1, 2000; 21(8): 1521 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Eckert and G. Yan Mutational analyses of dinucleotide and tetranucleotide microsatellites in Escherichia coli: influence of sequence on expansion mutagenesis Nucleic Acids Res., July 15, 2000; 28(14): 2831 - 2838. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Hile, G. Yan, and K. A. Eckert Somatic Mutation Rates and Specificities at TC/AG and GT/CA Microsatellite Sequences in Nontumorigenic Human Lymphoblastoid Cells Cancer Res., March 1, 2000; 60(6): 1698 - 1703. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |